CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $37,943
- in 1 filing
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,584,591. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-31 | Williamson Robert F III Director | Purchase | +55,000 | $1.38 | $76K | 423,792 |
| 2024-05-29 | Williamson Robert F III Director | Purchase | +11,375 | $1.32 | $15K | 350,136 |
| 2024-05-29 | Williamson Robert F III Director | Purchase | +18,656 | $1.34 | $25K | 368,792 |
| 2024-04-23 | Austin Mark John VP Finance/Prin Fin&Acct Offic | Option exercise | +30,000 | $0.36 | $11K | 84,030 |
| 2024-04-23 | Austin Mark John VP Finance/Prin Fin&Acct Offic | Option exercise · Stock option (right to buy) | −30,000 | 120,000 | ||
| 2024-03-06 | Lantheus Alpha Therapy, LLC 10% owner | Purchase 10b5-1 | +60,431,039 | $0.95 | $57.4M | 116,773,394 |
| 2024-01-30 | Williamson Robert F III Director | Purchase | +18,579 | $0.71 | $13K | 230,134 |
| 2024-01-30 | Williamson Robert F III Director | Purchase | +5,127 | $0.71 | $4K | 235,261 |
| 2024-01-30 | Williamson Robert F III Director | Purchase | +57,121 | $0.71 | $41K | 292,382 |
| 2024-01-30 | Williamson Robert F III Director | Purchase | +42,879 | $0.72 | $31K | 335,261 |
| 2024-01-30 | Williamson Robert F III Director | Purchase | +3,500 | $0.70 | $2K | 338,761 |
| 2024-01-29 | Williamson Robert F III Director | Purchase | +4,031 | $0.64 | $3K | 190,320 |
| 2024-01-29 | Williamson Robert F III Director | Purchase | +21,235 | $0.64 | $14K | 211,555 |
| 2024-01-26 | Williamson Robert F III Director | Purchase | +12,250 | $0.61 | $7K | 87,926 |
| 2024-01-26 | Williamson Robert F III Director | Purchase | +14,850 | $0.61 | $9K | 102,776 |
| 2024-01-26 | Williamson Robert F III Director | Purchase | +8,513 | $0.59 | $5K | 111,289 |
| 2024-01-26 | Williamson Robert F III Director | Purchase | +25,000 | $0.55 | $14K | 136,289 |
| 2024-01-26 | Williamson Robert F III Director | Purchase | +50,000 | $0.54 | $27K | 186,289 |
| 2024-01-25 | Williamson Robert F III Director | Purchase | +22,134 | $0.49 | $11K | 75,676 |
| 2024-01-24 | Puhlmann Markus Chief Medical Officer | Purchase | +280,000 | $0.50 | $140K | 1,375,425 |
Page 4 of 26 · 502 trades